Advertisement

The Role of SDD in Liver Transplantation: a Meta-Analysis

  • Peter H. J. van der Voort
  • Hendrick K. F. van Saene

Abstract

Wiesner et al. introduced SDD as infection prophylaxis in liver transplantation in 1987 and 1988 [1, 2]. These investigators reasoned that liver transplant recipients are the prime subset of patients to benefit from SDD prophylaxis for three reasons:
  1. 1.

    Liver transplant recipients are at high risk of infection

     
  2. 2.

    Most infections are endogenous following gut overgrowth

     
  3. 3.

    The potential pathogens causing infection in liver transplant recipients are aerobic Gram-negative bacilli (AGNB) and yeasts, the target microorganisms of SDD.

     

Keywords

Liver Transplantation Orthotopic Liver Transplantation Liver Transplant Recipient Liver Transplant Patient Selective Digestive Decontamination 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Wiesner RH, Hermans P, Rakela J et al (1987) Selective bowel decontamination to prevent gram-negative bacterial and fungal infection following orthotopic liver transplantation. Transplant Proc 19(1 Pt 3):2420–2423PubMedGoogle Scholar
  2. 2.
    Wiesner RH, Hermans PE, Rakela J et al (1988) Selective bowel decontamination to decrease gram-negative aerobic bacterial and Candida colonization and prevent infection after orthotopic liver transplantation. Transplantation 45:570–574PubMedCrossRefGoogle Scholar
  3. 3.
    Arnow PM (1995) Prevention of bacterial infection in the transplant recipient. The role of selective bowel decontamination. Infect Dis Clin North Am 9:849–862PubMedGoogle Scholar
  4. 4.
    Wiesner RH (1990) The incidence of Gram-negative bacterial and fungal infections in liver transplant patient treated with selective decontamination. Infection 18[Suppl 1]:S19–S21PubMedCrossRefGoogle Scholar
  5. 5.
    Losada I, Cuervas-Mons V, Damaso IMD (2002) Infeccion precoz en el paciente con trasplante hepatico: incidencia, gravedad, factores de riesgo y sensibilidad antibiotica de los aislados bacterianos. Enferm Infecc Microbiol Clin 20:422–430PubMedGoogle Scholar
  6. 6.
    Dupeyron C, Mangeney N, Sedrati L et al (1994) Rapid emergence of quinolone resistance in cirrhotic patients treated with norfloxacin to prevent spontaneous bacterial peritonitis. Antimicrob Agents Chemother 38:340–344PubMedGoogle Scholar
  7. 7.
    Van Saene HKF, Zandstra DF (2004) Selective decontamination of the digestive tract: rationale behind evidence based use in liver transplantation. Liver Transpl 10:828–833PubMedCrossRefGoogle Scholar
  8. 8.
    Cuervas-Mons V, Barrios C, Garrido A et al (1989) Bacterial infections in liver transplant patients under selective decontamination with norfloxacin. Transplant Proc 21:3558PubMedGoogle Scholar
  9. 9.
    Van Zeijl JH, Kroes ACM, Metselaar HJ et al (1990) Infections after auxiliary partial liver transplantation. Experiences in the first ten patients. Infection 18:146–151PubMedCrossRefGoogle Scholar
  10. 10.
    Rosman C, Klompmaker IJ, Bonsel GJ et al (1990) The efficacy of selective bowel decontamination as infection prevention after liver transplantation. Transplant Proc 22:1554–1555PubMedGoogle Scholar
  11. 11.
    Corti A, Sabbadini D, Pannacciulli, E et al (1991) Early severe infections after othotopic liver transplantation. Transplant Proc 23:1964PubMedGoogle Scholar
  12. 12.
    Gorensek MJ, Carey WD, Washington JA et al (1993) Selective bowel decontamination with quinolones and nystatin reduces gram-negative and fungal infections in orthotopic liver transplant recipients. Cleve Clin J Med 60:139–144PubMedGoogle Scholar
  13. 13.
    Smith SD, Jackson RJ, Hannakan CJ et al (1993) Selective decontamination in pediatric liver tranplants. Transplantation 55:1306–1309PubMedCrossRefGoogle Scholar
  14. 14.
    Bion JF, Badger I, Crosby HA et al (1994) Selective decontamination of the digestive tract reduces Gram-negative pulmonary colonisation but not systemic endotoxemia in patients undergoing elective liver transplantation. Crit Care Med 110:303–310Google Scholar
  15. 15.
    Steffen R, Reinhartz O, Blumhardt G (1994) Bacterial and fungal colonization and infections using oral selective bowel decontamination in orthotopic liver transplantations. Transplant Int 7:101–108CrossRefGoogle Scholar
  16. 16.
    Decruyenaere J, Colardyn F, Vogelaers D et al (1995) Combined use of fluconazole and selective digestive decontamination in the prevention of fungal infection after adult liver transplantation. Transplant Proc 27:3515–3516PubMedGoogle Scholar
  17. 17.
    Arnow PM, Carandang GC (1996) Randomized controlled trial of selective bowel decontamination for prevention of infections following liver transplantation. Clin Infect Dis 22:997–1003PubMedGoogle Scholar
  18. 18.
    Kuo PC, Bartlett ST, Lim JW et al (1997) Selective bowel decontamination in hospitalized patients awaiting liver transplantation. Am J Surg 174:745–749PubMedCrossRefGoogle Scholar
  19. 19.
    Hjortrup A, Rasmussen A, Hansen BA et al (1997) Early bacterial and fungal infections in liver transplantation after oral selective bowel decontamination. Transplant Proc 29:3106–3110PubMedCrossRefGoogle Scholar
  20. 20.
    Ermre S, Sebatian A, Chodoff L et al (1999) Selective decontamination of the digestive tract helps prevent bacterial infections in the early postoperative period after liver transplant. Mt Sinai J Med 66:310–313Google Scholar
  21. 21.
    Hellinger WC, Yao JD, Alvarez S et al (2002) A randomized, prospective, double-blinded evaluation of selective bowel decontamination in liver transplantation. Transplantation 73:1904–1909PubMedCrossRefGoogle Scholar
  22. 22.
    Zwaveling JH, Maring JK, Klompmaker IJ et al (2002) Selective decontamination of the digestive tract to prevent postoperative infection: a randomized placebo-controlled trial in liver transplant patients. Crit Care Med 30:1204–1209PubMedCrossRefGoogle Scholar
  23. 23.
    Rayes N, Seehofer D, Hansen S et al (2002) Early enteral supply of lactobacillus and fiber versus selective bowel decontamination: a controlled trial in liver transplant recipients. Transplantation 74:123–128PubMedCrossRefGoogle Scholar
  24. 24.
    Nathens AB, Marshall JC (1999) Selective decontamination of the digestive tract in surgical patients: a systematic review of the evidence. Arch Surg 134:170–176PubMedCrossRefGoogle Scholar
  25. 25.
    Safdar N, Said A, Lucey MR (2004) The role of selective digestive decontamination for reducing infection in patients undergoing liver transplantation: a systematic review and meta-analysis. Liver Transpl 10:817–827PubMedCrossRefGoogle Scholar
  26. 26.
    de Jonge E, Schultz MJ, Spanjaard L et al (2003) Effects of selective decontamination of digestive tract on mortality and acquisition of resistant bacteria in intensive care: a randomised controlled trial. Lancet 362:1011–1016PubMedCrossRefGoogle Scholar

Copyright information

© Springer 2008

Authors and Affiliations

  • Peter H. J. van der Voort
    • 1
  • Hendrick K. F. van Saene
    • 2
  1. 1.Department of Intensive CareOnze Lieve Vrouwe GasthuisAmsterdamThe Netherlands
  2. 2.Department of Clinical Microbiology and Infection ControlRoyal Liverpool Children’s NHS Trust of Alder HeyLiverpoolUK

Personalised recommendations